Related Experiment Video
Updated: Dec 22, 2025
07:45
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
6.8K
Experimental Breast Cancer Models: Preclinical Imaging Perspective.
1Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey.
Current Radiopharmaceuticals
|May 9, 2020
Summary
Experimental breast cancer models are crucial for understanding disease progression and developing targeted therapies. Choosing the right model is key, as each has unique advantages and disadvantages for preclinical imaging and theranostics.
Area of Science:
- Oncology
- Translational Research
- Medical Imaging
Background:
- Breast cancer is a leading cause of mortality in women, often due to metastasis.
- Targeted therapies show promise due to breast cancer's unique genetic profile.
- Experimental tumor models are vital for studying cancer pathogenesis and progression.
Purpose of the Study:
- To review existing literature on experimental breast cancer models.
- To offer a new perspective on using these models for theranostic preclinical imaging.
Main Methods:
- Literature search of academic databases using keywords: Breast cancer, theranostic, preclinical imaging, tumor models, animal study, tailored therapy.
- Full-text review and reevaluation of current scientific data.
- Compilation of findings organized by subtitles.
Main Results:
- Animal models for breast cancer research have evolved over the past century.
- Imaging techniques in breast cancer research aid in tumor localization, mass quantification, gene/protein imaging, microenvironment assessment, proliferation/metabolism studies, and treatment response evaluation.
Conclusions:
- No single experimental model can fully represent the genetic and phenotypic heterogeneity of human breast cancer.
- Each model possesses distinct advantages and limitations.
- Selecting the most appropriate model is essential for validating research hypotheses in breast cancer studies.
